Gontero, P, Soria, F, Babjuk, M, Burger, M, Comperat, E, Mostafid, H, Redorta, JP, Roupret, M, Van Rhijn, BW, Zigeuner, R, Shariat, SF, Cohen, D, Masson-Lecomte, A, Xylinas, E, Mariappan, P, Rai, BP, Capoun, O, Soukup, V, Thalmann, G, Pradere, B, Seisen, T, Dominguez-Escrig, JL, Liedberg, F, Sylvester, RJ. Individual patient data validation of the definitions of BCG failure in patients with non-muscle invasive urothelial carcinoma of the bladder: An international multicentre retrospective study. EUROPEAN UROLOGY. 2024; 85DOI:. PMID:. IF:25.200(Q1/1D).

Amparore, D, Pecoraro, A, Bertolo, R, Marchioni, M, Roussel, E, Pavan, N, Erdem, S, Wu, Z, Sharma, G, Pandolfo, SD, Warren, H, Caliò, A, Carbonara, U, Breda, A, Simone, G, Capitanio, U, Minervini, A, Campi, R, Palumbo, C. Small renal masses in young adults: Insights from a large contemporary multiinstitutional Registry. EUROPEAN UROLOGY. 2024; 85DOI:. PMID:. IF:25.200(Q1/1D).

De Santis, M, Redorta, JP, Nishiyama, H, Krawczynski, M, Seyitkuliev, A, Novikov, A, Guerrero-Ramos, F, Zukov, R, Kato, M, Kawahara, T, Goeman, L, Puente, J, Hellmis, E, Powles, T, Radziszewski, P, Gust, KM, Vasey, P, Bigot, P, Fradet, Y, Hunting, J, Armstrong, J, Boulos, S, Hois, S, Shore, ND. Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial. LANCET. 2025; 406(10516)DOI:10.1016/S0140-6736(25)01897-5. PMID:41115436. IF:88.500(Q1/1D).

Talyshinskii, A, Khairley, G, Tur, AB, Gauhar, V, Skolarikos, A, Tursunkulov, A, Ventimiglia, E, Dragos, L, De Coninck, V, Somani, BK. Role of pediatric ureteroscopy for large renal stones: a systematic review and meta-analysis from EAU endourology. WORLD JOURNAL OF UROLOGY. 2025; 43(1)DOI:10.1007/s00345-025-06053-x. PMID:41176750. IF:2.900(Q2/3D).